| A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study R Sun, EJ Limkin, M Vakalopoulou, L Dercle, S Champiat, SR Han, ... The Lancet Oncology 19 (9), 1180-1191, 2018 | 970 | 2018 |
| Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology EJ Limkin, R Sun, L Dercle, EI Zacharaki, C Robert, S Reuzé, ... Annals of Oncology 28 (6), 1191-1206, 2017 | 649 | 2017 |
| Prediction of cervical cancer recurrence using textural features extracted from 18F-FDG PET images acquired with different scanners S Reuzé, F Orlhac, C Chargari, C Nioche, E Limkin, F Riet, A Escande, ... Oncotarget 8 (26), 43169, 2017 | 143 | 2017 |
| The complexity of tumor shape, spiculatedness, correlates with tumor radiomic shape features EJ Limkin, S Reuzé, A Carré, R Sun, A Schernberg, A Alexis, E Deutsch, ... Scientific reports 9 (1), 4329, 2019 | 94 | 2019 |
| Hypoxia imaging and adaptive radiotherapy: a state-of-the-art approach in the management of glioma M Gérard, A Corroyer-Dulmont, P Lesueur, S Collet, M Chérel, ... Frontiers in medicine 6, 117, 2019 | 71 | 2019 |
| Baseline lymphopenia should not be used as exclusion criteria in early clinical trials investigating immune checkpoint blockers (PD-1/PD-L1 inhibitors) R Sun, S Champiat, L Dercle, S Aspeslagh, E Castanon, EJ Limkin, ... European Journal of Cancer 84, 202-211, 2017 | 35 | 2017 |
| A score combining baseline neutrophilia and primary tumor SUVpeak measured from FDG PET is associated with outcome in locally advanced cervical cancer A Schernberg, S Reuze, F Orlhac, I Buvat, L Dercle, R Sun, E Limkin, ... European journal of nuclear medicine and molecular imaging 45, 187-195, 2018 | 34 | 2018 |
| Locally advanced cervical cancer with bladder invasion: clinical outcomes and predictive factors for vesicovaginal fistulae R Sun, I Koubaa, EJ Limkin, I Dumas, E Bentivegna, E Castanon, S Gouy, ... Oncotarget 9 (10), 9299, 2018 | 29 | 2018 |
| 45 or 50 Gy, which is the optimal radiotherapy pelvic dose in locally advanced cervical cancer in the perspective of reaching magnetic resonance image-guided adaptive … R Mazeron, C Petit, E Rivin, E Limkin, I Dumas, P Maroun, P Annede, ... Clinical Oncology 28 (3), 171-177, 2016 | 26 | 2016 |
| Does East meet West? Towards a unified vision of the management of Nasopharyngeal carcinoma EJ Limkin, P Blanchard The British Journal of Radiology 92 (1102), 20190068, 2019 | 18 | 2019 |
| Implementation of image-guided brachytherapy as part of non-surgical treatment in inoperable endometrial cancer patients S Espenel, M Kissel, MA Garcia, A Schernberg, S Gouy, S Bockel, ... Gynecologic Oncology 158 (2), 323-330, 2020 | 15 | 2020 |
| Computational medical imaging (radiomics) and potential for immuno-oncology R Sun, EJ Limkin, L Dercle, S Reuzé, EI Zacharaki, C Chargari, ... Cancer radiotherapie: journal de la Societe francaise de radiotherapie …, 2017 | 14 | 2017 |
| Vaginal dose assessment in image-guided brachytherapy for cervical cancer: Can we really rely on dose-point evaluation? EJ Limkin, I Dumas, ER Del Campo, C Chargari, P Maroun, P Annède, ... Brachytherapy 15 (2), 169-176, 2016 | 12 | 2016 |
| Radiation therapy in the Philippines: A challenge in resourcefulness JPA Cañal, EJC Limkin International Journal of Radiation Oncology, Biology, Physics 94 (1), 7-10, 2016 | 11 | 2016 |
| Improving radiotherapy workflow through implementation of delineation guidelines & AI-based annotation M Ung, A Rouyar-Nicolas, E Limkin, C Petit, T Sarrade, A Carre, G Auzac, ... Int. J. Radiat. Oncol 108, e315, 2020 | 10 | 2020 |
| Adjuvant or salvage radiation therapy for prostate cancer after prostatectomy: Current status, controversies and perspectives M Terlizzi, EJ Limkin, Y Moukasse, P Blanchard Cancers 14 (7), 1688, 2022 | 8 | 2022 |
| Machine-learning-based radiomics MRI model for survival prediction of recurrent glioblastomas treated with bevacizumab S Ammari, R Sallé de Chou, T Assi, M Touat, E Chouzenoux, A Quillent, ... Diagnostics 11 (7), 1263, 2021 | 7 | 2021 |
| Imagerie médicale computationnelle (radiomique) et potentiel en immuno-oncologie R Sun, EJ Limkin, L Dercle, S Reuzé, EI Zacharaki, C Chargari, ... Cancer/Radiothérapie 21 (6-7), 648-654, 2017 | 7 | 2017 |
| Radiomics to predict response to immunotherapy: an imminent reality? EJ Limkin, R Sun Future Oncology 16 (23), 1673-1676, 2020 | 5 | 2020 |
| Is single fraction the future of stereotactic body radiation therapy (SBRT)? A critical appraisal of the current literature M Terlizzi, E Limkin, N Sellami, G Louvel, P Blanchard Clinical and Translational Radiation Oncology 39, 100584, 2023 | 4 | 2023 |
Roger SUNRadiation Oncology & Radiomics team, INSERM U1030, Gustave Roussy Cancer Center, Paris在 gustaveroussy.fr 的电子邮件经过验证
